JD HEALTH6618.HKValuation Analysis
Based on the blended 10-year P/E and P/B percentiles, the stock currently sits in the “Deeply Undervalued” zone.
As of Oct 16, 2026, JD HEALTH (6618.HK) trades at a P/E of 17.30x, P/B of 1.74x, P/S of 1.36x, and a dividend yield of 0.00%.
Longitudinal percentile comparison: P/E sits at the 5th percentile over the trailing 10Y window (vs. 6th percentile over 3Y); P/B sits at the 20th percentile over the trailing 10Y window (vs. 38th percentile over 3Y); P/S sits at the 8th percentile over the trailing 10Y window (vs. 17th percentile over 3Y).
Cross-sectional valuation: its P/E ranks at the 40th percentile within its industry and the 68th percentile across the broader market.
Shareholder return highlight: Total Shareholder Yield is 0.68%, ranking at the 95th percentile over the trailing 20Y window.
The P/E and P/B long-window percentiles differ by only 14.4 points, pointing to a consistent valuation read across both metrics. Relative to industry peers, its P/E shows a deeper discount than it does against the broader market. Shareholder returns here lean heavily on buybacks rather than cash dividends. JD HEALTH operates in the Industrial Internet sector. Data refreshes weekly and is for reference only, not investment advice.
Also listed as: HKG: 6618 · SEHK: 6618 · 6618
Want the full picture on whether JD HEALTH (6618.HK) is under- or over-valued? See the full 3Y / 5Y / 10Y / 20Y P/E, P/B, P/S, Dividend Yield & Total Shareholder Yield percentile matrix and the interactive ECharts trend chart on this page.
Historical Percentiles by Metric
| Metric | Current | Market Percentile | Industry Percentile | 3Y Pctl | 5Y Pctl | 10Y Pctl | 20Y Pctl |
|---|---|---|---|---|---|---|---|
| P/E (TTM) | 17.30 | ||||||
| P/B (MRQ) | 1.74 | ||||||
| P/S (TTM) | 1.36 | ||||||
| Dividend Yield | 0.00% | 0 | 0 | 0 | 0 | 0 | 0 |
| Buyback + Div Yield | 0.68% |